RNCOS has recently added a new Market Research Report titled, “Interferon Market Forecast to 2015” to its report gallery. One of the most effective clinical methods, used to treat a wide spectrum of diseases, protein-based therapies have found a prominent place in the biopharmaceutical industry. According to our new research report, the market for interferons (IFN), a family of glycoprotein cytokines which have antiviral, anti-proliferative, and immuno-modulatory properties, is expected to cross the US$ 10 Billion-mark by 2015. Increasing number of Hepatitis B and Hepatitis C cases across the globe will fuel growth in the market.

Our comprehensive report, “Interferon Market Forecast to 2015”, says that though the consumption of the interferon drugs is increasing, the segment is being hit by patent expirations. The study also looked into the shares of interferon beta and interferon alpha in the overall market. It also studied how the interferon market is performing in key geographies. It was found that Japan represents the largest market for interferon in Asia, and the third biggest in the world.

On studying the competitive landscape in the global interferon market, it was found that Biogen dominates the beta interferon market, followed by Merck. A brief overview of the activities of these key players has been included in the research work to depict a meaningful and clear picture of the market to clients.

For FREE SAMPLE of this report visit: www.rncos.com/Report/IM431.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015 (www.rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

NONE

B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

This release was published on openPR.